Work

TP-0184 Inhibits ALK2/ACVR1, Decreases Hepcidin Levels, and Demonstrates Activity in Preclinical Mouse Models of Functional Iron Deficiency

Year: 2017

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.937.937

Authors: Peter Peterson, W K, Clifford Whatcott, Adam Siddiqui-Jain, Steven Weitman, Mark Kieran, David J. Bearss, Steven L. Warner

Institutions: Tolero Pharmaceuticals (United States), Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Iron Metabolism and Disorders

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2968467301

Cites:

Cited by: 4

Related to: 10